James E. Thompson
- Hematology top 2%
- Acute Myeloid Leukemia Research 39
- Chronic Myeloid Leukemia Treatments 22
- Cancer Research top 2%
- Immunology top 5%
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 11
- Histone Deacetylase Inhibitors Research 9
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
-
- Acute Lymphoblastic Leukemia research 10
-
- Synthesis and biological activity 7
- Co-authors
- Stephen C. FryPaul TempstSankar GhoshHediye Erdjument‐BromageRonald T. RainesCraig B. ThompsonEunice S. WangDean Sheppard
- Cited by
- HematologyCancer ResearchImmunology
- Journals
- Blood (25 papers)Bioorganic & Medicinal Chemistry Letters (12 papers)Leukemia Research (7 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
James E. Thompson
135 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Hematology 613
- Cancer Research 658
- Immunology 716
- Molecular Biology 2.2k
- Genetics 306
Countries citing papers authored by James E. Thompson
This map shows the geographic impact of James E. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Thompson more than expected).
Fields of papers citing papers by James E. Thompson
This network shows the impact of papers produced by James E. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Thompson. The network helps show where James E. Thompson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James E. Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 3 | |
| 6 | 2020 | 1 | |
| 7 | 2012 | 89 | |
| 8 | 2011 | 45 | |
| 9 | 2010 | 7 | |
| 10 | 2008 | 29 | |
| 11 | 2008 | 9 | |
| 12 | 2006 | 11 | |
| 13 | The Genesis of the 1906 Trades Disputes Act | 1998 | 0 |
| 14 | 1998 | 9 | |
| 15 | IκB-β regulates the persistent response in a biphasic activation of NF-κBbreakdown → | 1995 | 691 |
| 16 | 1991 | 2 | |
| 17 | Case 277/87, Sandoz Prodotti Farmaceutici S.p.a. v. Commission of the European Communities , Judgment of 11 January 1990, (competition – notion of agreement); Case 279/87, Tipp-Ex GmbH & Co. KG v. Commision of the European Communities , Judgment of 8 February 1990. | 1990 | 0 |
| 18 | 1988 | 95 | |
| 19 | 1987 | 48 | |
| 20 | Language in Wycherley's plays : seventeenth-century language theory and drama | 1984 | 6 |
About James E. Thompson
James E. Thompson is a scholar working on Hematology, Genetics and Molecular Biology, having authored 148 papers that have together received 4.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (39 papers), Chronic Myeloid Leukemia Treatments (22 papers), Melanoma and MAPK Pathways (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Histone Deacetylase Inhibitors Research (9 papers) and Synthesis and biological activity (7 papers). The work is most often cited by research in Hematology (613 citations), Cancer Research (658 citations) and Immunology (716 citations). James E. Thompson has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Stephen C. Fry, Paul Tempst, Sankar Ghosh, Hediye Erdjument‐Bromage, Ronald T. Raines, Craig B. Thompson, Eunice S. Wang, Dean Sheppard, Martin Carroll and Meir Wetzler. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, Leukemia Research, Biochemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.